IRD vs MS · rev $11.0M vs P/E 20, $344.27B cap
Opus Genetics, Inc. (IRD) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
MS does not have a complete income-statement cache yet.
IRD currently screens at market cap $35.7M. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the IRD and MS stock pages for the full models.
Not investment advice.